Ultrasound of prostate cancer

European Radiology

Volumn 11, Issue 11, 2001, Pages 2119-2125

  Clements, R ^a  

^a ROYAL GWENT HOSPITAL   (United Kingdom)

Author keywords

Colour Doppler; Contrast agents; Prostate cancer; Transrectal ultrasound

Indexed keywords

CONTRAST MEDIUM;

ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EVALUATION; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; TECHNIQUE; TRANSRECTAL ULTRASONOGRAPHY; BIOPSY; ECHOGRAPHY; PATHOLOGY; PROSTATE TUMOR; REVIEW; VASCULARIZATION;

BIOPSY; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 0035231841     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003300101028     Document Type: Article

References (50)

1. The importance of patient preference in the decision to screen for prostate cancer
2. Trends in the diagnosis of stage T1A-B prostate cancer
3. The definition and preoperative prediction of clinically insignificant prostate cancer
4. Distinguishing clinically important from unimportant prostate cancers before treatment: Value of systematic biopsies
5. Biological determinants of cancer progression in men with prostate cancer
6. Vascular density is a predictor of cancer specific survival in prostatic carcinoma
7. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting
8. The prostatic gland: Malignancies other than adenocarcinomas
9. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer
10. An analysis of 148 consecutive transition zone cancers: Clinical and histological characteristics
11. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values
12. Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate
13. Hypoechoic lesions of the prostate: Clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen
14. 3) hypoechoic lesions in men with normal digital rectal examinations and prostate-specific antigen levels less than 10 ng/ml
15. Prostatic comedocarcinoma: Correlation of sonograms with pathologic specimens in three cases
16. The appearance of adenoid cystic carcinoma of the prostate on transrectal ultrasonography
17. From the archives of the AFIP. Genitourinary rhabdomyosarcoma in children: Radiologic-pathologic correlation
18. Sonographic and radiological features of cystosarcoma phyllodes of the prostate
19. A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate
20. Using gray-scale and color and power Doppler sonography to detect prostatic cancer
21. Color Doppler as an adjunct to prostate ultrasound
22. Prostate cancer and the role of color Doppler US
23. Prostatic cancer: Role of color Doppler imaging in transrectal sonography
24. Power Doppler in prostate cancer
25. Effect of the number of core biopsies of the prostate on predicting gleason score of prostate cancer
26. Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy
27. Developments in ultrasound contrast media
28. Transrectal ultrasound microbubble contrast angiography of the prostate
29. Prolongation and optimisation of Doppler enhancement with a microbubble US contrast agent by using a continuous infusion: Preliminary experience
30. Three-dimensional contrast-enhanced power Doppler ultrasonography and conventional examination methods: The value of diagnostic predictors of prostate cancer
31. Do intravascular ultrasound Doppler contrast agents improve transrectal ultrasound diagnosis of prostate cancer?
32. Contrast enhanced color Doppler ultrasound in the diagnostic evaluation of prostate cancer
33. Prostate cancer: Contrast-enhanced us for detection
34. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate
35. Sensitivity and specificity of sextant biopsies in the detection of prostate cancer: Preliminary report
36. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer
37. A model for the number of cores per prostate biopsy based on the patient age and prostate gland volume
38. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: Results of a prospective clinical trial
39. Lateral biopsies added to the traditional sextant prostate biopsy pattern increases the detection rate of prostate cancer
40. Use of three additional mid biopsies to improve local assessment of prostate cancer in patients with one positive sextant biopsy
41. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate
42. Value of systematic transition zone biopsies in the early detection of prostate cancer
43. Impact of transition zone biopsies in detection and evaluation of prostate cancer
44. Transrectal ultrasound guided prostate biopsy: Defining a new standard
45. Repeat prostate needle biopsy: Who needs it?
46. Diagnostic yield of repeated transrectal ultrasound guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels
47. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies
48. Periprostatic local anesthesia before ultrasound guided prostate biopsy
49. Ability of sextant biopsies to predict radical prostatectomy stage
50. Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values